Methodology of antiemetic trials: A review

Annals of Oncology

Volumn 2, Issue 2, 1991, Pages 107-114

  Tonato, M ^a   Roila, F ^a   Favero, A Del ^b  

^a Monteluce Polyclinic   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Antiemetic trials; Chemotherapy induced emesis

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; DEXAMETHASONE; DIPHENHYDRAMINE; METHYLPREDNISOLONE; METOCLOPRAMIDE;

ANTIEMETIC ACTIVITY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; HUMAN; NAUSEA; REVIEW; VOMITING;

EID: 0025978471     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a057871     Document Type: Review

References (34)

1. Carey M.P. Burish T.G. Brenner D.E. Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issues Ann Intern Med 99 1983 106 114
2. Pater J.L. Willan A.R. Methodologic issues in trials of antiemetics J Clin Oncol 2 1984 484 487
3. Morrow G.R. The assessment of nausea and vomiting. Past problems, current issues, and suggestions for future research Cancer 53 suppl 1984 2267 2280
4. Olver I.N. Simon R.M. Aisner J. Antiemetic studies: a methodological discussion Cancer Treat Rep 70 1986 555 563
5. Roila F. Tonato M. Basurto C. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone vs metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research J Clin Oncol 7 1989 1693 1700
6. Roila F. Tonato M. Basurto C. Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research Cancer Treat Rep 69 1985 1353 1357
7. Roila F. Tonato M. Basurto C. Antiemetic activity of high doses of metoclopramide combined with methylprednisolone vs metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research J Clin Oncol 5 1987 141 149
8. Becouarn Y. Bui N.B. David M. Improved control of cisplatin induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single blind randomized trial Eur J Cancer Clin Oncol 22 1986 1421 1424
9. Alba E. Bastus R. Castro I. Metoclopramida mas difenhidramina frente a clorpromacina en los vomitos inducidos por cisplatino. Estudio aleatorizado cruzado y a doble ciego Med Clin (Barc) 89 1987 410 412
10. Mellink W.A. Blijham G.H. Van Deyk W.A. Amitriptyline plus fluphenazine to prevent chemotherapy-induced emesis in cancer patients: a double-blind randomized cross-over study Eur J Cancer Clin Oncol 20 1984 1147 1150
11. Martin-Jimenez M. Diaz-Rubio E. Clinical evaluation of the simultaneous blockade of the dopamine D-2, histamine H-1, and muscarinic cholinergic receptors in cancer chemotherapy-induced emesis; results of a controlled trial Cancer Chemother Pharmacol 18 1986 168 171
12. Walsh T.D. Antiemetic drug combinations in advanced cancer Lancet 1 1982 1018
13. Benrubi G.I. Norvell M. Nuss R.C. The use of methylprednisolone in control of emesis in patients receiving cis-platinum Gynecol Oncol 21 1985 306 313
14. Osterwalder B. Wilder-Smith C. Schimke J. Antiemetic combination of metoclopramide, cinnarizine and lorazepam for patients with cisplatin-based combination chemotherapy Proc ASCO 7 1988 298
15. Meyer B.R. Lewin M. Drayer D.E. Optimizing metoclopramide control of cisplatin-induced emesis Ann Intern Med 100 1984 393 395
16. Kessler J.F. Alberts D.S. Plezia P.M. An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Experience in eighty-four patients Cancer Chemother Pharmacol 16 1986 282 286
17. Roila F. Basurto C. Minotti V. Methylprednisolone versus metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide methotrexate 5-fluorouracil: a double-blind randomized study Oncology 45 1988 346 349
18. Kris M.G. Tyson L.B. Gralla R.J. Extrapyramidal reactions with high-dose metoclopramide N Engl J Med 309 1983 433
19. Roberts W.S. Berman M. DiSaia P.J. Letter to the Editor Gynecol Oncol 17 1984 249
20. Aapro M.S. Plezia P.M. Alberts D.S. Double-blind cross-over study of the antiemetic efficacy of high-dose dexamethasone vs high-dose metoclopramide J Clin Oncol 2 1984 466 471
21. Fritak S. Moertel C.G. O'Fallon J. Delta-9-tetrahydrocannabinol as an antiemetic in patients treated with cancer chemotherapy: a double comparison with prochlorperazine and a placebo Ann Intern Med 91 1979 825 830
22. Vincent B.J. McQuistion D.J. Einhorn L.H. Review of cannabinoids and their antiemetic effectiveness Drugs 25 1983 52 62
23. Gralla R.J. Tyson L.B. Kris M.G. The management of chemotherapy-induced nausea and vomiting Med Clin North Am 71 1987 289 301
24. Gez E. Catane R. Pfau L. High-dose metoclopramide as an antiemetic in patients receiving cis-platinum-based combination chemotherapy Gynecol Oncol 21 1985 18 22
25. D'Acquisto R.W. Tyson L.B. Gralla R.J. The influence of a chronic high alcohol intake on chemotherapy-induced nausea and vomiting Proc ASCO 5 1986 257
26. Sullivan J.R. Leyden M.J. Bell R. Decreased cisplatin-induced nausea and vomiting with chronic alcohol ingestion N Engl J Med 309 1983 796
27. Morrow G.R. Susceptibility to motion sickness and the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy Cancer Treat Rep 68 1984 1177 1178
28. Martin M. Diaz-Rubio E. Emesis during past pregnancy: a new factor in chemotherapy-induced emesis Annals of Oncology 1 1990 152 153
29. Pollera C.F. Giannarelli D. Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model Cancer 64 1989 1117 1122
30. Kris M.G. Gralla R.J. Tyson L.B. Improved control of cisplatin induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients Cancer 55 1985 527 534
31. Cubeddu L.X. Hoffmann I.S. Fuenmayor N.T. Efficacy of ondansetron (GR38032F) and the role of serotonin in cisplatin induced nausea and vomiting N Engl J Med 322 1990 810 816
32. Armitage P. Sequential medical trials 1960 Blackwell Oxford
33. Smyth J.F. The problem of emesis induced by cancer chemotherapy Clinician 6 1988 2 12
34. Del Favero A. Roila F. Basurto C. Assessment of nausea Eur J Clin Pharmacol 38 1990 115 120